Qiagen N.V. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
4 Biotech Stocks To Buy For The Q2 2021
Article By: StockNews
Monday, April 5, 2021 6:45 AM EDT
The global biotechnology market is expected to expand at a CAGR of 15.8% between 2021 – 2028.
In this article: JAZZ, AMGN, GILD, QGEN
Read
Thermo Fisher Acquires Qiagen For EUR 39 Per Share In Cash Or $11.5B
Article By: The Fly
Tuesday, March 3, 2020 5:52 AM EDT
Thermo Fisher Scientific and Qiagen announced that their boards have unanimously approved Thermo Fisher's proposal to acquire Qiagen for EUR 39 per share in cash.
In this article: TMO, QGEN
Read
Week In Review: Beigene Sets Record With $1.4 Billion Celgene Deal
Article By: ChinaBio® Today
Saturday, July 8, 2017 2:35 PM EDT
BeiGene of Beijing has entered a "transformational" collaboration with Celgene which involves BeiGene's clinical-stage PD-1 immuno-oncology drug, has a total value of almost $1.4 billion.
In this article: CELG, QGEN, BGNE, BYSI, ATNX
Read
Week In Review: Ping An Announces $1 Billion Fin-Tech/Healthcare VC Fund
Article By: ChinaBio® Today
Saturday, May 6, 2017 5:13 PM EDT
Ping An Insurance Group, China's largest insurer by market value, announced plans to launch a $1 billion international fund that will invest in fin-tech and healthcare startups. Ping An is already a player in the fin-tech area with Lufax.
In this article: SRNE, QGEN
Read
New Stocks On Most Attractive/Most Dangerous: January 2017
Article By: David Trainer
Friday, January 13, 2017 10:20 AM EDT
Our Most Attractive stocks have high and rising returns on invested capital and low price to economic book value ratios. Most Dangerous stocks have misleading earnings and long growth appreciation periods implied by their market valuations.
In this article: HAS, QGEN Also: VOXX, DLTR, FRAN, IDCC
Read

Latest Tweets for $QGEN

No tweets yet!

PARTNER HEADLINES